XORTX Therapeutics Statistics
NASDAQ: XRTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.75+0.005 (+0.29%)
Market open · Delayed 15 min · as of Oct 8, 9:36 AM ET
XORTX Therapeutics by the numbers
XORTX Therapeutics has a market capitalization of $3.2 million based on 1.82M shares outstanding. With trailing EPS of $-2.61, XORTX Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 13.7% below its 50-day average and 22.8% below its 200-day average.
Average daily trading volume is 225.78K shares, or about $395,106 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
XRTX valuation vs. peer median
| Metric | XRTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.18M | $3.19M | -0% |
| Avg. volume | 225.78K | 376.79K | -40% |
Peer median across 8 companies: CVKD, KAPA, PRFX, REVB, ONCO, APVO, GOVX, MBIO.
Valuation
- Market cap
- $3.18M
- Forward P/E
- 2.18
- EPS (TTM)
- $-2.61
- Shares outstanding
- 1.82M
Price and trading
- Previous close
- 1.75
- Open
- 1.75
- Day range
- 1.75 – 1.75
- 52-week range
- 1.59 – 7.05
- Beta
- —
- Volume
- 2.04K
- Average volume
- 225.78K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 15, 2026
Additional statistics
- Market Cap
- 3.18M
- Forward Pe
- 2.18
- Eps
- -2.61
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.05
- Week52 Low
- 1.59
- Avg Volume
- 225.78K
- Shares Outstanding
- 1.82M
- Ma50
- 2.03
- Ma200
- 2.27
- Earnings Date
- Aug 15, 2026
- Pct From52w High
- -75.18%
- Pct From52w Low
- 10.06%